IBM to sell Watson’s brainpower to speed clinical and academic research
IBM Thursday rolled out yet another healthcare use for its Watson computing technology, namely to help academic and clinical researchers sort through mountains of research data.
Watson is known for its ability to understand natural language and develop its own conclusions from it. IBM intends to sell this newest Watson service, dubbed Watson Discovery Advisor, as a software-as-a-service product.
The new service, if it lives up to expectations, could have a major impact in fields like molecular and comparative effectiveness, its initial partners say.
Read more: Modern Healthcare